These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11847542)

  • 1. Coronary Arteriography Should Not Be Routinely Used Postinfarction in Patients Having Received Thrombolytic Therapy.
    Plante S; Juneau C; Rouleau JL
    Am J Ther; 1995 Feb; 2(2):141-145. PubMed ID: 11847542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators.
    Rogers WJ; Babb JD; Baim DS; Chesebro JH; Gore JM; Roberts R; Williams DO; Frederick M; Passamani ER; Braunwald E
    J Am Coll Cardiol; 1991 Apr; 17(5):1007-16. PubMed ID: 1901071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic therapy: adjuvant mechanical intervention for acute myocardial infarction.
    Muller DW; Topol EJ
    Am J Cardiol; 1992 Jan; 69(2):60A-70A. PubMed ID: 1729880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.
    Rogers WJ; Baim DS; Gore JM; Brown BG; Roberts R; Williams DO; Chesebro JH; Babb JD; Sheehan FH; Wackers FJ
    Circulation; 1990 May; 81(5):1457-76. PubMed ID: 2110033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial.
    Chaitman BR; McMahon RP; Terrin M; Younis LT; Shaw LJ; Weiner DA; Frederick MM; Knatterud GL; Sopko G; Braunwald E
    Am J Cardiol; 1993 Jan; 71(2):131-8. PubMed ID: 8421972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction. TAMI Study Group.
    Kereiakes DJ; Califf RM; George BS; Ellis S; Samaha J; Stack R; Martin LH; Young S; Topol EJ
    Am Heart J; 1991 Aug; 122(2):390-9. PubMed ID: 1907087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II).
    Ruocco NA; Bergelson BA; Jacobs AK; Frederick MM; Faxon DP; Ryan TJ
    J Am Coll Cardiol; 1992 Dec; 20(7):1445-51. PubMed ID: 1452916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients after myocardial infarction and thrombolytic therapy.
    O'Rourke RA
    Curr Probl Cardiol; 1994 Apr; 19(4):179-226. PubMed ID: 8205834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Treatment of Post-Thrombolytic Stenoses (TOPS) Study Group.
    Ellis SG; Mooney MR; George BS; da Silva EE; Talley JD; Flanagan WH; Topol EJ
    Circulation; 1992 Nov; 86(5):1400-6. PubMed ID: 1423952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of predischarge radionuclide ventriculography at rest and exercise after acute myocardial infarction treated with thrombolytic therapy or primary coronary angioplasty. The Zwolle Myocardial Infarction Study Group.
    Gosselink AT; Liem AL; Reiffers S; Zijlstra F
    Clin Cardiol; 1998 Apr; 21(4):254-60. PubMed ID: 9562935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing prognosis after acute myocardial infarction in the thrombolytic era.
    Gimple LW; Beller GA
    J Nucl Cardiol; 1994; 1(2 Pt 1):198-209. PubMed ID: 9420687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.
    Circulation; 1994 Apr; 89(4):1545-56. PubMed ID: 8149520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predischarge exercise radionuclide angiography in predicting multivessel coronary artery disease and subsequent cardiac events after thrombolytic therapy for acute myocardial infarction.
    Zhu WX; Gibbons RJ; Bailey KR; Gersh BJ
    Am J Cardiol; 1994 Sep; 74(6):554-9. PubMed ID: 8074037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of negative predischarge exercise testing in identifying patients at low risk after acute myocardial infarction treated by systemic thrombolysis.
    Piccalò G; Pirelli S; Massa D; Cipriani M; Sarullo FM; De Vita C
    Am J Cardiol; 1992 Jul; 70(1):31-3. PubMed ID: 1615866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise testing after myocardial infarction: with or without therapy? How does thrombolysis affects its predictivity?
    Bernabò P; Mazzotta G
    Monaldi Arch Chest Dis; 2003 Mar; 60(1):55-61. PubMed ID: 12827834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ischemia-guided approach for risk stratification in patients with acute coronary syndromes.
    Pepine CJ
    Am J Cardiol; 2000 Dec; 86(12B):27M-35M. PubMed ID: 11206016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reperfusion therapy and mechanical circulatory support in patients in cardiogenic shock].
    Scholz KH
    Herz; 1999 Oct; 24(6):448-64. PubMed ID: 10546149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Barbash GI; Roth A; Hod H; Modan M; Miller HI; Rath S; Zahav YH; Keren G; Motro M; Shachar A
    Am J Cardiol; 1990 Sep; 66(5):538-45. PubMed ID: 2118299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
    Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
    J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group.
    Zaret BL; Wackers FJ; Terrin ML; Forman SA; Williams DO; Knatterud GL; Braunwald E
    J Am Coll Cardiol; 1995 Jul; 26(1):73-9. PubMed ID: 7797778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.